Prevention of stress- or nitric oxide donor-induced medication overuse headache by a calcitonin gene-related peptide antibody in rodents

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Cephalalgia

• Publication date

  2017-05-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1177/0333102416650702PMID 27206958
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Correction: Krymchantowski, A.V.; et al. Medication-Overuse Headache: Differences between Daily and Near-Daily Headache Patients; Brain Sciences 2016, 6, 30

  2017cited by this paper
• TEV-48125: a Review of a Monoclonal CGRP Antibody in Development for the Preventive Treatment of Migraine

  2015cited by this paper
• Therapeutic antibodies against CGRP or its receptor.

  2015cited by this paper
• Safety, tolerability, and efficacy of TEV-48125 for preventive treatment of chronic migraine: a multicentre, randomised, double-blind, placebo-controlled, phase 2b study.

  2015cited by this paper
• Site of effect of LY2951742 for migraine prophylaxis--authors' reply.

  2015cited by this paper
• Safety and efficacy of LY2951742, a monoclonal antibody to calcitonin gene-related peptide, for the prevention of migraine: a phase 2, randomised, double-blind, placebo-controlled study.

  2014cited by this paper
• Evaluation of cardiovascular parameters in cynomolgus monkeys following IV administration of LBR-101, a monoclonal antibody against calcitonin gene-related peptide

  2014cited by this paper
• Safety and efficacy of ALD403, an antibody to calcitonin gene-related peptide, for the prevention of frequent episodic migraine: a randomised, double-blind, placebo-controlled, exploratory phase 2 trial.

  2014cited by this paper
• Anti-CGRP antibodies for migraine turn industry heads

  2014cited by this paper
• Nitric oxide synthase, calcitonin gene-related peptide and NK-1 receptor mechanisms are involved in GTN-induced neuronal activation

  2014cited by this paper
• Safety and tolerability of LBR-101, a humanized monoclonal antibody that blocks the binding of CGRP to its receptor: Results of the Phase 1 program

  2014cited by this paper
• The calcitonin gene-related peptide receptor antagonist MK-8825 decreases spinal trigeminal activity during nitroglycerin infusion

  2013cited by this paper
• Migraine: The Seventh Disabler

  2013cited by this paper
• In Vivo Quantification of Calcitonin Gene-Related Peptide Receptor Occupancy by Telcagepant in Rhesus Monkey and Human Brain Using the Positron Emission Tomography Tracer [11C]MK-4232

  2013cited by this paper
• Calcitonin Gene‐Related Peptide (CGRP) and Migraine Current Understanding and State of Development

  2013cited by this paper
• Migraine: The seventh disabler

  2013cited by this paper
• Primary trigeminal afferents are the main source for stimulus-induced CGRP release into jugular vein blood and CSF

  2012influential reference
• Medication-Overuse Headache

  2012influential reference
• Calcitonin gene-related peptide in migraine: intersection of peripheral inflammation and central modulation

  2011cited by this paper
• Bright light activates a trigeminal nociceptive pathway

  2010cited by this paper
• Calcitonin gene-related peptide: A molecular link between obesity and migraine?

  2010cited by this paper
• Triptan-induced enhancement of neuronal nitric oxide synthase in trigeminal ganglion dural afferents underlies increased responsiveness to potential migraine triggers.

  2010cited by this paper
• CGRP and its receptors provide new insights into migraine pathophysiology

  2010cited by this paper
• An Analysis of Migraine Triggers in a Clinic‐Based Population

  2010cited by this paper
• Triptan‐induced latent sensitization: A possible basis for medication overuse headache

  2009cited by this paper
• Opiate-Induced Persistent Pronociceptive Trigeminal Neural Adaptations: Potential Relevance to Opiate-Induced Medication Overuse Headache

  2009cited by this paper
• Medullary pain facilitating neurons mediate allodynia in headache‐related pain

  2009cited by this paper
• Randomized controlled trial of an oral CGRP receptor antagonist, MK-0974, in acute treatment of migraine

  2008cited by this paper
• Sumatriptan Causes Parallel Decrease in Plasma CGRP Concentration and Migraine Headache During Nitroglycerin-Induced Migraine Attack: Reply

  2006cited by this paper
• Sumatriptan Causes Parallel Decrease in Plasma CGRP Concentration and Migraine Headache During Nitroglycerin-Induced Migraine Attack

  2006cited by this paper
• Central Sensitization Theory of Migraine: Clinical Implications

  2006cited by this paper
• Calcitonin gene-related peptide receptor antagonist BIBN 4096 BS for the acute treatment of migraine.

  2004cited by this paper
• NO‐induced migraine attack: strong increase in plasma calcitonin gene‐related peptide (CGRP) concentration and negative correlation with platelet serotonin release

  2003cited by this paper
• Cgrp May Play A Causative Role in Migraine

  2002cited by this paper
• Levels of nerve growth factor in cerebrospinal fluid of chronic daily headache patients

  2001cited by this paper
• An association between migraine and cutaneous allodynia

  2000cited by this paper
• Nitric oxide supersensitivity: a possible molecular mechanism of migraine pain.

  1993cited by this paper
• Vasoactive peptide release in the extracerebral circulation of humans during migraine headache

  1990cited by this paper

• Cortical astrocyte activation triggers meningeal nociception and migraine-like pain

  2025cites this paper
• Efficacy of different cannabinoid compounds on migraine-like responses in female rats

  2025cites this paper
• Towards zebrafish models of migraine.

  2025cites this paper
• Efficacy and Safety of Erenumab in Adults With Medication Overuse Headache: Final Results From a Phase 4 Randomized Placebo‐Controlled Study

  2025cites this paper
• Dipyrone induces sex-dependent latent sensitization in a preclinical model of medication overuse headache.

  2025cites this paper
• Cortical astrocyte activation triggers meningeal nociception and migraine-like pain.

  2025cites this paper
• Induction of more severe central sensitization in a medication overuse headache model mice through active ingestion of rizatriptan

  2025cites this paper
• Novel insight into atogepant mechanisms of action in migraine prevention

  2024cites this paper
• Efficacy of Monoclonal Antibodies Against Calcitonin Gene-Related Peptide for Medication Overuse Headache in Migraine Patients: Literature Review

  2024cites this paper
• Regulatory T cells require peripheral CCL2-CCR2 signaling to facilitate the resolution of medication overuse headache-related behavioral sensitization

  2024cites this paper
• An Automated Squint Method for Time-syncing Behavior and Brain Dynamics in Mouse Pain Studies.

  2024cites this paper
• Efficacy and Safety of Erenumab for Nonopioid Medication Overuse Headache in Chronic Migraine

  2024cites this paper
• Beyond Pain: The Effects of OnabotulinumtoxinA Therapy on Sensitization and Interictal Symptoms in Chronic Migraine

  2024cites this paper
• CGRP-targeted medication in chronic migraine - systematic review

  2024cites this paper
• Characterizing opioid use in a Dutch cohort with migraine

  2023cites this paper
• Medication Over Use Headache: Characteristic, Etiopathophysiology, Diagnosis and Emerging Treatment

  2023cites this paper
• Preventive CGRP-targeted therapies for chronic migraine with and without medication-overuse headache

  2023cites this paper
• Semi-Automated Recording of Facial Sensitivity in Rat Demonstrates Antinociceptive Effects of the Anti-CGRP Antibody Fremanezumab

  2023cites this paper
• Neurobiology of migraine progression

  2022cites this paper
• Dysregulation of serum prolactin links the hypothalamus with female nociceptors to promote migraine.

  2022cites this paper
• Therapies targeting CGRP signaling for medication overuse headache.

  2022cites this paper
• Atogepant – an orally-administered CGRP antagonist – attenuates activation of meningeal nociceptors by CSD

  2022cites this paper
• Role of endothelin in the pathophysiology of migraine: A new view on an old player.

  2022cites this paper
• Efficacy of Ubrogepant in the Acute Treatment of Migraine With Mild Pain vs Moderate or Severe Pain

  2022cites this paper
• CGRP Antibodies for Animal Models of Primary and Secondary Headache Disorders

  2021cites this paper
• CGRP and Immune Modulation: Evidence-Based Therapy

  2021cites this paper
• The Evolution of Medication Overuse Headache: History, Pathophysiology and Clinical Update

  2021influential citation
• Safety and Risk of Medication Overuse Headache in Lasmiditan and Second-Generation Gepants: A Rapid Review

  2021cites this paper
• Medication overuse headache: Divergent effects of new acute antimigraine drugs

  2020influential citation
• Cannabinoids induce latent sensitization in a preclinical model of medication overuse headache

  2020cites this paper
• Acid‐sensing ion channel 3 blockade inhibits durovascular and nitric oxide‐mediated trigeminal pain

  2020cites this paper
• Low-dose interleukin-2 reverses behavioral sensitization in multiple mouse models of headache disorders.

  2020cites this paper
• Pharmacological treatment of migraine: CGRP and 5-HT beyond the triptans.

  2020cites this paper
• CGRP Therapeutics For The Treatment Of Migraine – A Narrative Review

  2020cites this paper
• Increased severity of closed head injury or repetitive subconcussive head impacts enhances post-traumatic headache-like behaviors in a rat model

  2020cites this paper
• Ubrogepant does not induce latent sensitization in a preclinical model of medication overuse headache

  2020cites this paper
• The impact of fremanezumab on medication overuse in patients with chronic migraine: subgroup analysis of the HALO CM study

  2020cites this paper
• Medication overuse in a subgroup analysis of phase 3 placebo-controlled studies of galcanezumab in the prevention of episodic and chronic migraine

  2020cites this paper
• Pharmacological Characterization of Orofacial Nociception in Female Rats Following Nitroglycerin Administration

  2020cites this paper
• Nitroglycerin as a comparative experimental model of migraine pain: From animal to human and back

  2019cites this paper
• CGRP in Animal Models of Migraine.

  2019cites this paper
• Contribution of intraganglionic CGRP to migraine-like responses in male and female rats

  2019cites this paper
• CGRP-dependent and independent mechanisms of acute and persistent post-traumatic headache following mild traumatic brain injury in mice

  2019cites this paper
• Fremanezumab in the treatment of migraines: evidence to date

  2019cites this paper
• Targeting CGRP via receptor antagonism and antibody neutralisation in two distinct rodent models of migraine-like pain

  2019cites this paper
• Migraine: Experimental Models and Novel Therapeutic Approaches

  2019cites this paper
• Pathophysiology, prevention, and treatment of medication overuse headache.

  2019cites this paper
• The need for new acutely acting antimigraine drugs: moving safely outside acute medication overuse

  2019influential citation
• Fremanezumab as a preventive treatment for episodic and chronic migraine

  2019cites this paper
• Migraine-Associated TRESK Mutations Increase Neuronal Excitability through Alternative Translation Initiation and Inhibition of TREK.

  2019cites this paper
• Enhanced post-traumatic headache-like behaviors and diminished contribution of peripheral CGRP in female rats following a mild closed head injury

  2019cites this paper
• Headaches in Idiopathic Intracranial Hypertension

  2019cites this paper
• Medication overuse headache following repeated morphine, but not [INCREMENT]9-tetrahydrocannabinol administration in the female rat

  2018cites this paper
• Animal Models in Chronic Daily Headache (CDH) and Pathophysiology of CDH

  2018cites this paper
• Intact mast cell content during mild head injury is required for the development of latent pain sensitization - implications for mechanisms underlying post-traumatic headache

  2018cites this paper
• TRPA1/NOX in the soma of trigeminal ganglion neurons mediates migraine-related pain of glyceryl trinitrate in mice

  2018cites this paper
• The Biology of Monoclonal Antibodies: Focus on Calcitonin Gene-Related Peptide for Prophylactic Migraine Therapy

  2018cites this paper
• Development of CGRP-dependent pain and headache related behaviours in a rat model of concussion: Implications for mechanisms of post-traumatic headache

  2018cites this paper
• The Effect of Beginning Treatment With Fremanezumab on Headache and Associated Symptoms in the Randomized Phase 2 Study of High Frequency Episodic Migraine: Post‐Hoc Analyses on the First 3 Weeks of Treatment

  2018cites this paper
• From LBR-101 to Fremanezumab for Migraine

  2018cites this paper
• Sustained exposure to acute migraine medications combined with repeated noxious stimulation dysregulates descending pain modulatory circuits: Relevance to medication overuse headache

  2018cites this paper
• Analysis of the anti-migraine effects of THC using home cage wheel running

  2017cites this paper
• Kappa opioid receptor antagonists: A possible new class of therapeutics for migraine prevention

  2017influential citation
• Animal models of pain and migraine in drug discovery.

  2017cites this paper